Bismuth Hyaluronate, the Preparation Method and the Use Thereof
    1.
    发明申请
    Bismuth Hyaluronate, the Preparation Method and the Use Thereof 有权
    透明质酸铋,其制备方法及其用途

    公开(公告)号:US20080312429A1

    公开(公告)日:2008-12-18

    申请号:US12095797

    申请日:2006-12-01

    IPC分类号: C08B37/08 C07H23/00

    CPC分类号: A61K31/728 C08B37/0072

    摘要: The present invention discloses a bismuth hyaluronate, characterized in that the bismuth content is from 0.5% to 40%, and the glucuronate content is from 20% to 45%, based on dry weight. Also provided is a method for the preparation of said bismuth hyaluronate comprising reaction of a soluble hyaluronate salt with a bismuth salt in a basic aqueous solution, followed by steps of precipitation, filtration, desalting, dehydrating and drying to obtain the product. Further disclosed is the use of the bismuth hyaluronate in the manufacture of a medicament or health foods for preventing and treating gastrointestinal disorders, in particular ulcerous disorders of the GI tract. It has been proven in animal experiments to show a better therapeutic effect than products of the same type.

    摘要翻译: 本发明公开了一种透明质酸铋,其特征在于,所述铋含量为0.5〜40%,所述葡萄糖醛酸酯含量为20〜45%。 还提供了一种制备所述透明质酸铋的方法,包括在碱性水溶液中使可溶性透明质酸盐与铋盐反应,然后进行沉淀,过滤,脱盐,脱水和干燥以获得产物。 进一步披露的是透明质酸铋在制造用于预防和治疗胃肠道疾病,特别是胃肠道溃疡性疾病的药物或保健食品中的用途。 在动物实验中已经证明比相同类型的产品显示更好的治疗效果。

    Preparation and Application of Heparin Silver
    2.
    发明申请
    Preparation and Application of Heparin Silver 有权
    肝素银的制备与应用

    公开(公告)号:US20080269164A1

    公开(公告)日:2008-10-30

    申请号:US11912123

    申请日:2006-04-20

    摘要: The present invention relates to a method for preparation of heparin silver, to use of heparin silver in manufacture of medicine for treating burns and/or scalds, to a method of using heparin silver to treat burns and/or scalds, and to a topic topical preparation containing heparin silver for treating burns and/or scalds. The heparin silver product prepared according to the method of the present invention has a high purity and less impurity. The animal test proved that the medicine made by using heparin silver exhibited effects of accelerating wound healing and reducing scar formation.

    摘要翻译: 本发明涉及肝素银的制备方法,肝素银制造用于治疗烧伤和/或烫伤的药物,使用肝素银治疗烧伤和/或烫伤的方法,以及主题专题 含有肝素银的制剂用于治疗烧伤和/或烫伤。 根据本发明的方法制备的肝素银产品具有高纯度和较少的杂质。 动物试验证明,使用肝素银制成的药物具有加速伤口愈合和减少瘢痕形成的作用。

    Preparation and application of heparin silver
    3.
    发明授权
    Preparation and application of heparin silver 有权
    肝素银的制备与应用

    公开(公告)号:US08735363B2

    公开(公告)日:2014-05-27

    申请号:US11912123

    申请日:2006-04-20

    摘要: The present invention relates to a method for preparation of heparin silver, to use of heparin silver in manufacture of medicine for treating burns and/or scalds, to a method of using heparin silver to treat burns and/or scalds, and to a topical preparation containing heparin silver for treating burns and/or scalds. The heparin silver product prepared according to the method of the present invention has a high purity and less impurity. The animal test proved that the medicine made by using heparin silver exhibited effects of accelerating wound healing and reducing scar formation.

    摘要翻译: 本发明涉及肝素银制备方法,肝素银制造用于治疗烧伤和/或烫伤的药物,使用肝素银治疗烧伤和/或烫伤的方法,以及局部制剂 含有肝素银用于治疗烧伤和/或烫伤。 根据本发明的方法制备的肝素银产品具有高纯度和较少的杂质。 动物试验证明,使用肝素银制成的药物具有加速伤口愈合和减少瘢痕形成的作用。

    Bismuth hyaluronate, the preparation method and the use thereof
    4.
    发明授权
    Bismuth hyaluronate, the preparation method and the use thereof 有权
    透明质酸铋,其制备方法及其用途

    公开(公告)号:US08093374B2

    公开(公告)日:2012-01-10

    申请号:US12095797

    申请日:2006-12-01

    IPC分类号: C08B37/08

    CPC分类号: A61K31/728 C08B37/0072

    摘要: The present invention discloses a bismuth hyaluronate, characterized in that the bismuth content is from 0.5% to 40%, and the glucuronate content is from 20% to 45%, based on dry weight. Also provided is a method for the preparation of said bismuth hyaluronate comprising reaction of a soluble hyaluronate salt with a bismuth salt in a basic aqueous solution, followed by steps of precipitation, filtration, desalting, dehydrating and drying to obtain the product. Further disclosed is the use of the bismuth hyaluronate in the manufacture of a medicament or health foods for preventing and treating gastrointestinal disorders, in particular ulcerous disorders of the GI tract. It has been proven in animal experiments to show a better therapeutic effect than products of the same type.

    摘要翻译: 本发明公开了一种透明质酸铋,其特征在于,所述铋含量为0.5〜40%,所述葡萄糖醛酸酯含量为20〜45%。 还提供了一种制备所述透明质酸铋的方法,包括在碱性水溶液中使可溶性透明质酸盐与铋盐反应,然后进行沉淀,过滤,脱盐,脱水和干燥以获得产物。 进一步披露的是透明质酸铋在制造用于预防和治疗胃肠道疾病,特别是胃肠道溃疡性疾病的药物或保健食品中的用途。 在动物实验中已经证明比相同类型的产品显示更好的治疗效果。